RCM and Genetics Testing
RCM is actively involved in the emerging use of Genetic testing to better understand certain Retinal Conditions. Working with Blueprint Genetics, RCM tests a wide variety of Variants, and helps connect patients and clinicians to future clinical trials. Blueprint testing may be conducted for individuals with a clinical diagnosis of an inherited retinal degeneration (IRD) living in the United States and US territories.